Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-α-induced depression model

[1]  S. O’Mara,et al.  Exercise prevents IFN-α-induced mood and cognitive dysfunction and increases BDNF expression in the rat , 2017, Physiology & Behavior.

[2]  M. Fava,et al.  Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. , 2017, Journal of affective disorders.

[3]  Andrew H. Miller,et al.  Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus , 2016, Physiology & Behavior.

[4]  D. Lysle,et al.  Acquisition of heroin conditioned immunosuppression requires IL-1 signaling in the dorsal hippocampus , 2016, Brain, Behavior, and Immunity.

[5]  H. Critchley,et al.  Acute Changes in Striatal Microstructure Predict the Development of Interferon-Alpha Induced Fatigue , 2016, Biological Psychiatry.

[6]  J. Zubieta,et al.  Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction , 2015, Molecular Psychiatry.

[7]  O. Steward,et al.  Rapamycin and Interleukin-1β Impair Brain-derived Neurotrophic Factor-dependent Neuron Survival by Modulating Autophagy* , 2014, The Journal of Biological Chemistry.

[8]  D. Sobieraj,et al.  Prevention of interferon‐alpha‐associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta‐analysis , 2014, International journal of clinical practice.

[9]  C. Callaghan,et al.  Neurotrophins play differential roles in short and long-term recognition memory , 2013, Neurobiology of Learning and Memory.

[10]  M. Gratacós,et al.  Serotonin and interleukin-6: The role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms , 2013, Psychoneuroendocrinology.

[11]  B. Kieffer,et al.  Opioid receptors: distinct roles in mood disorders , 2013, Trends in Neurosciences.

[12]  B. Kieffer,et al.  Impaired Hippocampus-Dependent and Facilitated Striatum-Dependent Behaviors in Mice Lacking the Delta Opioid Receptor , 2013, Neuropsychopharmacology.

[13]  C. Callaghan,et al.  Differential BDNF signaling in dentate gyrus and perirhinal cortex during consolidation of recognition memory in the rat , 2012, Hippocampus.

[14]  D. Slattery,et al.  Using the rat forced swim test to assess antidepressant-like activity in rodents , 2012, Nature Protocols.

[15]  M. Alavi,et al.  Effect of pegylated interferon‐α‐2a treatment on mental health during recent hepatitis C virus infection , 2012, Journal of gastroenterology and hepatology.

[16]  R. Bodnar.  Endogenous opiates and behavior: 2009 , 2010, Peptides.

[17]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[18]  Allison T. Knoll,et al.  Dynorphin, stress, and depression , 2010, Brain Research.

[19]  B. Pollock,et al.  Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality , 2009, Brain, Behavior, and Immunity.

[20]  I. Lucki,et al.  Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. , 2009, Journal of pharmacological and toxicological methods.

[21]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[22]  S. O’Mara,et al.  Interferon-α-induced deficits in novel object recognition are rescued by chronic exercise , 2008, Physiology & Behavior.

[23]  R. Balázs,et al.  Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction , 2008, Neurobiology of Aging.

[24]  I. Goshen,et al.  Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression , 2008, Molecular Psychiatry.

[25]  A. Pawełczyk,et al.  [Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients]. , 2008, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[26]  N. Kalin,et al.  Effects of Interferon-Alpha on Rhesus Monkeys: A Nonhuman Primate Model of Cytokine-Induced Depression , 2007, Biological Psychiatry.

[27]  M. Witter,et al.  Cingulate cortex projections to the parahippocampal region and hippocampal formation in the rat , 2007, Hippocampus.

[28]  S. O’Mara,et al.  The widely-used anti-viral drug interferon-alpha induces depressive- and anxiogenic-like effects in healthy rats , 2007, Behavioural Brain Research.

[29]  David P. Wolfer,et al.  Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice , 2007, Neurobiology of Learning and Memory.

[30]  G. Barker,et al.  Recognition Memory for Objects, Place, and Temporal Order: A Disconnection Analysis of the Role of the Medial Prefrontal Cortex and Perirhinal Cortex , 2007, The Journal of Neuroscience.

[31]  S. Kanba,et al.  Suppression of Cell Proliferation by Interferon-Alpha through Interleukin-1 Production in Adult Rat Dentate Gyrus , 2006, Neuropsychopharmacology.

[32]  Robert A Koeppe,et al.  Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. , 2006, Archives of general psychiatry.

[33]  R. Kumar,et al.  Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments , 2006, Neuropsychiatric disease and treatment.

[34]  J. Bauer,et al.  Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study , 2006, European Psychiatry.

[35]  Cécile Béguin,et al.  Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[36]  J. Bidlack,et al.  Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? , 2005, Neuropsychopharmacology.

[37]  G. Pagnoni,et al.  Anterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment , 2005, Biological Psychiatry.

[38]  S. Fukuda,et al.  Role of IL-6 in the neural stem cell differentiation , 2005, Clinical reviews in allergy & immunology.

[39]  M. Scheurlen,et al.  Neurocognitive Changes in Patients with Hepatitis C Receiving Interferon alfa‐2b and Ribavirin , 2005, Clinical pharmacology and therapeutics.

[40]  A. Cowan,et al.  Buprenorphine: a unique drug with complex pharmacology. , 2004, Current neuropharmacology.

[41]  R. Scheibel,et al.  Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. , 2004, The Journal of neuropsychiatry and clinical neurosciences.

[42]  R. Dantzer,et al.  Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy , 2004, Brain, Behavior, and Immunity.

[43]  S. Harvey,et al.  Role of Hippocampal CA3 μ-Opioid Receptors in Spatial Learning and Memory , 2004, The Journal of Neuroscience.

[44]  Hiroki Toda,et al.  Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.

[45]  Philip S. Portoghese,et al.  Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[46]  P. Peterson,et al.  Opioid G protein-coupled receptors: signals at the crossroads of inflammation. , 2003, Trends in immunology.

[47]  C. Tsigos,et al.  Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. , 2002, Journal of psychosomatic research.

[48]  H. Meltzer,et al.  Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System , 2002 .

[49]  A. Dierich,et al.  Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses , 2000, Nature Genetics.

[50]  A. Eschalier,et al.  Reversal of Learned Helplessness by Morphine in Rats Involvement of a Dopamine Mediation , 1998, Pharmacology Biochemistry and Behavior.

[51]  L. Terenius,et al.  Hippocampal dynorphin B injections impair spatial learning in rats: a κ-opioid receptor-mediated effect 1 Parts of these results were presented at the International Narcotics Research Conference 1995, St Andrews, U.K. 1 , 1998, Neuroscience.

[52]  P. Hauser,et al.  Mood and cognitive side effects of interferon-α therapy , 1998 .

[53]  E. Bosmans,et al.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.

[54]  J. Aggleton,et al.  Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix , 1997, Experimental Brain Research.

[55]  J. Pach,et al.  The hippocampus as a cognitive graph , 1996, The Journal of general physiology.

[56]  H. Loh,et al.  The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Talpaz,et al.  Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia , 1995, Neurology.

[58]  H. Akil,et al.  Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.

[59]  C. Stein,et al.  Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[60]  L. Hokkanen,et al.  Reversible cognitive decline during high-dose α-interferon treatment , 1994, Pharmacology Biochemistry and Behavior.

[61]  A Goldstein,et al.  Cloning and pharmacological characterization of a rat kappa opioid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Nishi,et al.  Primary structures and expression from cDNAs of rat opioid receptor δ‐and μ‐subtypes , 1993 .

[63]  J. F. Chen,et al.  Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum , 1993, Neuroscience.

[64]  P. Wood,et al.  μ-, δ-, κ- and ϵ-Opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides , 1987, Brain Research.

[65]  David J. Smith,et al.  Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro , 1987, Neuropharmacology.

[66]  H. Akil,et al.  Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain , 1987 .

[67]  R. Zukin,et al.  Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. O’Keefe,et al.  Hippocampal place units in the freely moving rat: Why they fire where they fire , 1978, Experimental Brain Research.

[69]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[70]  J. Bidlack,et al.  Syntheses and opioid receptor binding properties of carboxamido-substituted opioids. , 2009, Bioorganic & medicinal chemistry letters.

[71]  A. Eschalier,et al.  Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats , 2005, Psychopharmacology.

[72]  R. Houghtling,et al.  Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland. , 2002, The Journal of pharmacology and experimental therapeutics.

[73]  M. Makino,et al.  Human interferon-α increases immobility in the forced swimming test in rats , 2000, Psychopharmacology.

[74]  K. Miyata,et al.  Corticotropin-Releasing Hormone1 Receptors Mediate Consensus Interferon-α YM643-Induced Depression-Like Behavior in Mice , 2000 .

[75]  J. Aggleton,et al.  Identifying cortical inputs to the rat hippocampus that subserve allocentric spatial processes: A simple problem with a complex answer , 2000, Hippocampus.

[76]  M. Riva,et al.  Cellular Neuroscience Mini Review Article Brain-derived Neurotrophic Factor: a Bridge between Inflammation and Neuroplasticity , 2022 .